Erectile dysfunction treatment got a lot more crowded in the last few years, with telehealth startups turning a doctor’s-office conversation into a five-minute intake form. That shift is now under scrutiny. A 2023 audit of 15 direct-to-consumer ED platforms found that 14 of them opened with nothing more than an online questionnaire, and only 4 said outright that a physician would be the one reviewing it [6]. The pills themselves are not new and not mysterious. What has changed is how many doors lead to them, and how few of those doors have anyone checking who’s walking through.
That gap matters because the drugs at the center of all this, sildenafil, tadalafil, vardenafil and avanafil, are some of the more thoroughly studied medications in outpatient medicine. The American Urological Association lists them as first-line therapy for ED once a clinician has walked through the risks with a patient [1]. The evidence behind that recommendation is not vague. It’s measurable, it’s been measured more than once, and it comes with one hard stop that no amount of convenience should be allowed to skip.
What the trial numbers actually say
Start with the figure that matters most to anyone asking “does this stuff work.” In a randomized, double-blind, placebo-controlled trial of tadalafil 5 mg taken once daily, 48.6 percent of intercourse attempts succeeded by day two of treatment. The placebo group hit 36.6 percent over the same stretch, and the gap was statistically significant [4].
Two things jump out of that pairing. The drug clearly outperforms placebo, and it does it fast, inside 48 hours rather than weeks. But the placebo number is not a rounding error. More than a third of attempts succeeded with no active drug in the picture at all, a reminder that arousal, expectation and circumstance carry real weight in this particular outcome. Any writeup that quotes only the 48.6 percent and leaves out the 36.6 percent is telling half the story.
The dosing question with an actual answer
Tadalafil supports two different playbooks: a low daily dose, or a pill taken on demand before activity. This isn’t a coin flip. A meta-analysis in the journal Sexual Medicine pooled studies running at least 24 weeks and found that daily dosing delivered a better therapeutic effect with fewer treatment-emergent side effects than on-demand dosing over that stretch [3].
That doesn’t make daily dosing mandatory. On-demand means less total drug in a man’s system across a month, and some men will still prefer that tradeoff. But as a data-backed default, daily tadalafil at the low dose studied in the onset trial (5 mg) [4] has the pooled evidence in its corner for anyone weighing long-term use [3].
The evidence tier these drugs sit in
PDE5 inhibitors aren’t a novelty riding on marketing copy. The mechanism is worked out down to the biochemistry: the drug blocks the PDE5 enzyme that normally breaks down cyclic GMP, cyclic GMP builds up, smooth muscle relaxes, blood flow increases [2]. On top of that mechanism sits a stack of randomized, double-blind, placebo-controlled trials and pooled meta-analyses, which is about as high as drug evidence gets [3][4]. Mechanism and trial data point the same direction here, which is not something you can say about every supplement or off-label regimen making the rounds online.
The one number that overrides everything else
None of the efficacy data matters if the drug reaches the wrong person. PDE5 inhibitors combined with nitrate medications can cause a severe, life-threatening blood pressure crash. The prescribing reference is unambiguous: coadministration with nitrates is contraindicated, and nitrate use is only considered safe again after the drug has cleared the system, roughly 24 hours for sildenafil [2]. Men on nitrates for chest pain are, unhelpfully, among the most likely to want an ED prescription and among the most likely to be seriously harmed by getting one unchecked.
There’s a second flag worth reporting alongside it. The AUA guideline states plainly that ED itself can be an early warning sign of cardiovascular disease, and that men should be counseled about that link [1]. So the safety conversation isn’t really about the pill being dangerous on its own. It’s about the pill landing with someone it shouldn’t, or landing without anyone noticing what it might be signaling.
Where the data gets thinner
Worth flagging plainly: the headline 48.6-versus-36.6 figure comes from one onset-of-efficacy trial measuring one specific endpoint, and any individual result can land above or below a trial average, because trials track populations, not one guy on a random Tuesday [4]. The daily-versus-on-demand conclusion comes from a meta-analysis, which gains power by pooling studies but also blends different designs and populations into a single number, so there’s more variation under the hood than the clean headline suggests [3]. None of that undercuts the case for these drugs. It just means the numbers describe an average, not a guarantee.
The ranked practical picks
Reporting this out, three things stand above the noise:
1. Daily low-dose tadalafil, if long-term use is the plan. The pooled 24-week data gives it the edge over on-demand dosing on both effect and tolerability [3].
2. A clinic where a licensed physician actually reviews the case before anything ships, not just an intake form that auto-generates a prescription. Given that 14 of 15 platforms audited in 2023 skipped straight to a form and only 4 disclosed physician review [6], this is the step most likely to be quietly cut, and it’s the step that catches the nitrate contraindication before it becomes a hospital visit. FormBlends is worth naming here specifically because a clinician reviews the case inside the loop and dispensing runs through licensed pharmacies, which is the structural answer to the exact gap that report exposed. That’s a description of how the access is built, not a claim about guaranteed pricing or outcomes, and there’s nothing to buy on this page.
3. A real screening conversation about heart health, not a checkbox. ED as a cardiovascular warning sign [1] is reason enough that “did anyone ask about your nitrate use” should count as a bigger quality signal than any discount code.
Frequently asked questions
How much better than placebo is an ED pill, in actual numbers?
In a randomized, double-blind, placebo-controlled trial, 48.6 percent of intercourse attempts succeeded on tadalafil 5 mg by day two, versus 36.6 percent on placebo, a statistically significant difference [4]. The drug’s margin is real and shows up fast. The high placebo number is the part most coverage leaves out: a meaningful share of attempts succeed without any drug, because arousal, expectation and circumstance all factor into the outcome.
Is daily tadalafil better than taking it on demand?
For long-term use, the pooled data favors daily. A meta-analysis in Sexual Medicine covering studies of at least 24 weeks found daily tadalafil produced a preferable therapeutic effect with fewer treatment-emergent side effects than on-demand dosing [3]. Daily also removes the timing pressure, since the drug isn’t tied to a specific moment. On-demand still appeals to men who want less total drug exposure over a month, which is why this is a deliberate choice rather than a default setting.
Why can ED pills be dangerous with heart medication?
PDE5 inhibitors combined with nitrates can cause a severe, life-threatening blood pressure drop, which is why the combination is a hard contraindication [2]. Nitrate use is only considered safe again after the drug clears, roughly 24 hours for sildenafil [2]. Men on nitrates for chest pain are both the most likely to want an ED prescription and the most likely to be harmed by one that slips through unscreened, which is why this single check outweighs every efficacy statistic above it.
Does erectile dysfunction signal a bigger health problem?
It can. The American Urological Association guideline names ED as a risk marker for underlying cardiovascular disease and says men should be counseled about that connection [1]. In practice, a new case of ED sometimes surfaces before any other visible sign of a circulatory problem, which is one more reason the prescribing conversation should involve more than a form.
Does the choice of online clinic actually change the outcome?
Yes, because every efficacy figure above assumes the prescription reached the right person after the right screening. A 2023 audit of 15 direct-to-consumer ED platforms found 14 of 15 opened with an online intake form and only 4 disclosed physician review [6]. When the reviewer is hard to find, the screening step protecting against the nitrate contraindication is the step most at risk of getting skipped. A model where a clinician sits in the loop, like FormBlends, is built specifically to keep that step from disappearing.
How does an online ED clinic actually work, step by step?
A patient fills out a detailed health questionnaire, a licensed physician reviews it, and if it’s appropriate, a prescription goes to a pharmacy that ships it out. The process typically takes a few hours to a couple of days, and most platforms allow follow-up messaging if the dose needs adjusting. It mirrors an in-person visit in structure, minus the physical exam, which matters in some cases.
Is getting ED medication from an online clinic actually safe?
It’s safe when the clinic uses licensed physicians and dispenses through licensed pharmacies. The risk sits with unregulated sites that skip medical review entirely or ship unapproved compounds. Look for platforms that are transparent about their prescribers and their pharmacy partners. A site selling sildenafil with no clinical intake process at all is a red flag worth taking seriously.
What does an online ED clinic typically cost, and what affects the price?
Generic sildenafil from a legitimate online clinic generally runs somewhere between 30 and 90 dollars a month depending on dose and quantity, and prices shift often. Branded versions cost considerably more. Some clinics tack on a separate consultation fee, others fold it into the price. Compounding pharmacies working under physician supervision, such as FormBlends, sit at a different price point because the formulations are custom rather than off-the-shelf.
Do online ED clinics require a physical exam before prescribing?
Most don’t, and for otherwise healthy men with a clear clinical picture, that’s standard accepted practice. That said, urology and primary-care guidelines do recommend a baseline physical and cardiovascular check at some point, since ED can be an early sign of circulatory trouble. A clinic that never nudges a patient toward an in-person checkup is cutting a corner worth noticing.
References
- Erectile Dysfunction: AUA Guideline. American Urological Association (Burnett AL, et al.), published 2018, amended through 2018. Names FDA-approved oral PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) as first-line therapy unless contraindicated, and identifies ED as a risk marker for cardiovascular disease warranting patient counseling. https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
- Smith BP, Babos M. Sildenafil. StatPearls. NCBI Bookshelf (NBK558978). Describes sildenafil as a PDE5 inhibitor and first-line oral ED therapy acting via inhibition of cGMP degradation, and states that coadministration with nitrates is contraindicated because the combination can cause severe, life-threatening hypotension, with nitrate use considered safe only after roughly 24 hours. https://www.ncbi.nlm.nih.gov/books/NBK558978/
- Zhou Z, Chen H, Wu J, Wang J, Zhang X, Ma J, Cui Y. Meta-Analysis of the Long-Term Efficacy and Tolerance of Tadalafil Daily Compared With Tadalafil On-Demand in Treating Men With Erectile Dysfunction. Sex Med. 2019;7(3):282-291. DOI: 10.1016/j.esxm.2019.06.006. Concluded tadalafil daily provides a preferable therapeutic effect with a lower incidence of treatment-emergent adverse events relative to on-demand dosing over at least 24 weeks.
- Seftel AD, Goldfischer E, Kim ED, Dula E, Zeigler H, Burns P. Onset of efficacy of tadalafil once daily in men with erectile dysfunction: a randomized, double-blind, placebo controlled trial. J Urol. 2011;186(2):682-688. PMID: 21074803. Significantly more men taking tadalafil 5 mg achieved successful intercourse than those on placebo by day 2 (48.6% vs 36.6%, p < 0.025).
- Broffman L, Barnes M, Stern K, Westergren A. Evaluating the Quality of Asynchronous Versus Synchronous Virtual Care in Patients With Erectile Dysfunction: Retrospective Cohort Study. JMIR Form Res. 2022;6(1):e32126. PMID: 34905499; PMCID: PMC8796045. Found that for erectile dysfunction, asynchronous care can offer the same level of prescribing safety as synchronous care, with lower but nonsignificant differences in reported drug-related side effects.
- Brink SM, Iarajuli T, Shin D. Characteristics of direct-to-consumer platforms offering erectile dysfunction treatment. Sex Med. 2023;11(4):qfad038. PMID: 37547870; PMCID: PMC10397420. Of 15 DTC platforms, 14 (93%) began with an online intake form and only 4 (27%) explicitly advertised physician consultation.
Reported by Wes Tanaka, news-desk reporter, from the primary literature cited above. Last reviewed April 2026.
Not medical advice. Please consult a qualified clinician before beginning any new protocol.
